Paul Nardelli1, Randall Powers2, Tim C Cope1,3, Mark M Rich4. 1. School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA. 2. Department of Physiology and Biophysics, University of Washington, Seattle, WA. 3. Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA. 4. Department of Neuroscience, Cell Biology, and Physiology, Wright State University, Dayton, OH.
Abstract
OBJECTIVE: Weakness induced by critical illness (intensive care unit acquired weakness) is a major cause of disability in patients and is currently untreatable. We recently identified a defect in repetitive firing of lower motor neurons as a novel contributor to intensive care unit acquired weakness. To develop therapy for intensive care unit acquired weakness, it was necessary to determine the mechanism underlying the defect in repetitive firing. METHODS: Both computer simulation and in vivo dynamic voltage clamp of spinal motor neurons in septic rats were employed to explore potential mechanisms underlying defective repetitive firing. RESULTS: Our results suggest alteration in subthreshold voltage-activated currents might be the mechanism underlying defective repetitive firing. It has been shown previously that pharmacologic activation of serotonin receptors on motor neurons increases motor neuron excitability, in part by enhancing subthreshold voltage-activated inward currents. Administration of a U.S. Food and Drug Administration-approved serotonin agonist (lorcaserin) to septic rats greatly improved repetitive firing and motor unit force generation. INTERPRETATION: Our findings suggest activation of serotonin receptors with lorcaserin may provide the first ever therapy for intensive care unit acquired weakness in patients. Ann Neurol 2017;82:961-971.
OBJECTIVE:Weakness induced by critical illness (intensive care unit acquired weakness) is a major cause of disability in patients and is currently untreatable. We recently identified a defect in repetitive firing of lower motor neurons as a novel contributor to intensive care unit acquired weakness. To develop therapy for intensive care unit acquired weakness, it was necessary to determine the mechanism underlying the defect in repetitive firing. METHODS: Both computer simulation and in vivo dynamic voltage clamp of spinal motor neurons in septic rats were employed to explore potential mechanisms underlying defective repetitive firing. RESULTS: Our results suggest alteration in subthreshold voltage-activated currents might be the mechanism underlying defective repetitive firing. It has been shown previously that pharmacologic activation of serotonin receptors on motor neurons increases motor neuron excitability, in part by enhancing subthreshold voltage-activated inward currents. Administration of a U.S. Food and Drug Administration-approved serotonin agonist (lorcaserin) to septic rats greatly improved repetitive firing and motor unit force generation. INTERPRETATION: Our findings suggest activation of serotonin receptors with lorcaserin may provide the first ever therapy for intensive care unit acquired weakness in patients. Ann Neurol 2017;82:961-971.
Authors: Jeremy W Chopek; Christopher W MacDonell; Kevin E Power; Kalan Gardiner; Phillip F Gardiner Journal: J Neurophysiol Date: 2013-01-30 Impact factor: 2.714
Authors: Katherine C Murray; Marilee J Stephens; Edmund W Ballou; Charles J Heckman; David J Bennett Journal: J Neurophysiol Date: 2010-10-27 Impact factor: 2.714
Authors: Emily V Fletcher; Christian M Simon; John G Pagiazitis; Joshua I Chalif; Aleksandra Vukojicic; Estelle Drobac; Xiaojian Wang; George Z Mentis Journal: Nat Neurosci Date: 2017-05-15 Impact factor: 24.884
Authors: Leatha A Clark; Todd M Manini; Nathan P Wages; Janet E Simon; David W Russ; Brian C Clark Journal: J Gerontol A Biol Sci Med Sci Date: 2021-03-31 Impact factor: 6.053
Authors: Stephen N Housley; Paul Nardelli; Dario I Carrasco; Travis M Rotterman; Emily Pfahl; Lilya V Matyunina; John F McDonald; Timothy C Cope Journal: Cancer Res Date: 2020-04-28 Impact factor: 12.701
Authors: Altamash Hassan; Christopher K Thompson; Francesco Negro; Mark Cummings; Randall K Powers; C J Heckman; Julius P A Dewald; Laura Miller McPherson Journal: J Neural Eng Date: 2020-02-18 Impact factor: 5.379
Authors: Travis M Rotterman; Darío I Carrasco; Stephen N Housley; Paul Nardelli; Randall K Powers; Timothy C Cope Journal: PLoS One Date: 2021-11-19 Impact factor: 3.240